Identity of protease-based biomarkers for viability and cytotoxicity revealed by CRISPR knockouts

Puntos clave

• Protease-based biomarkers reveal significant insights into cellular viability and cytotoxicity, driving forward diagnostic applications.
• Key evidence includes specific protease knockouts that notably affect viability metrics, showing distinct cellular responses.
• Analysis was performed using CRISPR knockouts on diverse cell lines, highlighting the role of specific proteases in cytotoxicity.
• Findings underscore the potential to leverage protease biomarkers in clinical diagnostics, though further validation is warranted.